Want to join the conversation?
$CAG 4Q15 Call -John, CFO: The company expects EPS adjusted for items impacting comparability for fiscal first quarter of 2016, to be roughly in line with comparable year-ago quarter. We repaid approx. $1.1Bil of debt in FY15 and $2.1Bil since Ralcorp acquisition. This quarter, we repurchased about 12MM of shares.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.